New vaginal device shows promise for yeast infections in small trial
NCT ID NCT05507333
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a vaginal pessary (Gedea) in 26 women with yeast infections. Participants used the device daily for 6 days. Researchers checked if symptoms like itching and burning went away by day 7 to 14. The goal was to see if the device could safely treat the infection without medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gedea pessary (a vaginal insert device)
- What this could lead to
- If it works, this could offer a new non-drug option for treating yeast infections, potentially reducing symptoms and clearing the infection.
- What could go wrong
- This is a small, early-phase study with only 26 participants, so results may not apply to everyone. The device may not work as well as standard antifungal treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVOVAGINAL CANDIDIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CTC MTC
Uppsala, 75237, Sweden
-
Carlanderska
Gothenburg, 405 45, Sweden
-
Danderyds sjukhus
Stockholm, 182 88, Sweden
-
KS Huddinge
Stockholm, 141 86, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.